BRAMPTON, ON, Sept. 10, 2019 /CNW/ – CannabCo Pharmaceutical Corp. (CannabCo), a Canadian enterprise situated in Brampton, Ontario, is pleased to announce an agreement with an undisclosed technologies provider to deploy an sophisticated cannabis technologies for the production of close to odorless cannabis. This is an business very first and a solution the enterprise claims is sorely necessary in the marketplace. Upon getting its license from Well being Canada, CannabCo will have exclusive rights to deploy the technologies for use in its Canadian production.
Initially created for the healthcare market place and dubbed “PURECANN”, the technologies was made to get rid of significantly of the harshness of smoking cannabis by customers without having losing any of its properties. “ Cannabis by its nature when burnt, generally causes coughing and is really heavy when inhaled, which is in particular correct for new customers.” Commented Mark Novak, Cannabco’s COO. “The technologies when deployed eliminates significantly of the harshness of smoking cannabis in its dry type permitting the method of utilizing cannabis far a lot more tolerable when retaining the important properties”.
The technologies also practically eliminates odor generally linked with cannabis, each when packaged and stored prior to use, also in the course of the time it is smoked. “When we saw the technologies in action and the finish outcome, we realized there had been a quantity of possible markets linked with the use of PURECANN”, mentioned President and CEO Mark Pellicane, “There are no third-celebration gadgets, or devices on the portion of the user, the finish outcome is pure cannabis that doesn’t smell”.
Completely compliant with GMP requirements, the enterprise intends to use the technologies for production of solutions distributed to the healthcare and recreational markets. “Think about a person going outdoors for a break in the course of the day, obtaining their afternoon cannabis and coming back without having any odor attached to their clothes or coat.” commented Pellicane. “A lady can carry cannabis in her purse without having obtaining the odor concentrated or leaking out in her handbag. A quantity of customers, and folks that are about cannabis smokers, complain about the smell in particular in enclosed places, condos, and apartments, and this technologies addresses these issues.”
“More than the final two years we’ve observed solution becoming processed with the technique and we had been offered the chance to present feedback and ideas for the refinement of the method. We have been extremely pleased with the benefits” mentioned Novak. “In utilizing this technologies CannabCo will be in a position to create a wide selection of solutions at present not in the marketplace, addressing a important market place segment that at present does not exist.”
The tech enterprise has the following claims linked with implementing PURECANN:
- Practically undetectable odor of dry solution in the course of storage
- Drastically decreased cannabis odor (practically undetectable) in the course of combustion
- Reduces harshness resulting in a really smooth smoke on combustion
- May possibly be utilized to create a “connoisseur” solution for a exceptional market place segment
- Significantly less residual heavy feeling “day immediately after impact” linked with smoking cannabis
CannabCo is at present raising capital, constructing its pilot facility in Brampton, Ontario, and has received a Confirmation of Readiness notification from Well being Canada for their pending cannabis license. Cannabco intends to implement the PURECANN technologies upon completion of licensing by Well being and intends to create a quantity of solution lines addressing important segments in the healthcare and recreational markets.
Cannabco also lately announced the intention to deploy PHOENIX technologies for its indoor develop operations decreasing cannabis production fees to beneath $.50 per gram. “We intend to allocate a portion of solution cultivated with PHOENIX for the manufacture of specialty solutions utilizing PURECANN”, confirmed Novak.
The enterprise has not but decided if it will apply the technologies in the type of third celebration solutions for processing cannabis supplied from other Canadian producers having said that when asked, Pellicane commented “It’s a new technologies and performs hand in hand with PHOENIX, so there is a considerable benefit applying it to a portion of our cultivated solution, having said that we have not ruled out processing for other LP’s and practically nothing is at present off the table.” Cannabco at present maintains exclusive rights to deploy the technologies for its Canadian cultivation and manufacturing operations.
About CannabCo Pharmaceutical Corp.
CannabCo Pharmaceutical Corp. is a Canadian primarily based complete service cannabis enterprise with operations in Brampton, Ontario. The enterprise has received its “Confirmation of Readiness” from Well being Canada to turn into a licensed producer and is at present creating out its pilot facility in the Brampton Location. The enterprise intends to use an enhanced technologies identified as PHOENIX for its cultivation initiatives claiming a higher productivity and considerably reduce expense per gram than conventional grows. The enterprise intends to launch extraction initiatives as effectively as enter the oils, extracts, and consumable markets upon completion of its Brampton Facility. The facility is pursuing EU GMP status permitting access to the underserviced worldwide pharmaceutical market place.
Forward Searching Statements
This press release may well include specific “forward-searching details” and “forward-searching statements” inside the which means of applicable securities legislation. All details contained herein that is not historical in nature may well constitute forward-searching details. Forward-searching statements may well be identified by statements containing the words “believes”, “anticipates”, “plans”, “intends”, “will”, “really should”, “expects”, “continue”, “estimate”, “forecasts” and other related expressions. Actual benefits and developments may well differ materially from these contemplated by these statements. While CannabCo believes that the expectations reflected in forward-searching statements in this press release are affordable, there can be no assurance that such statements will prove to be precise. Future events and benefits could differ materially from these set forth in, contemplated by, or underlying the forward-searching statements in this press release. Comments and claims associated to PHOENIX and PURECANN are primarily based solely on that observed and the opinions of management as effectively as third celebration verifications supplied to CannabCo from business specialists.
Supply Cannabco Pharmaceutical Corp
The post CannabCo to launch Odorless Cannabis to the Canadian market place, a worldwide very first appeared very first on Terpenes and Testing Magazine.